Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Chiapparrone, G."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Umari, P., Rizzo, M., Billia, M., Chiapparrone, G., Pavan, N., Liguori, G., Stacul, F., Zacchero, M., De Angelis, P., Volpe, A., Trombetta, C.
Publikováno v:
In European Urology Supplements March 2018 17(2):e949-e952
Publikováno v:
Publons
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c551dc0b159da862f6efc1846f182d6
https://hdl.handle.net/11368/2918939
https://hdl.handle.net/11368/2918939
Autor:
Chiapparrone,G, Alonge,V, Caruso,S, Fanale,D, RUSSO, Antonio, Giaimo,RM, Sommatino,F, SERRETTA, Vincenzo
Introduction/Aim: Chemotherapy or BCG given intravesically to prevent recurrence after transurethral resection (TUR) of non-muscle invasive bladder cancer (NMI-BC) cause frequent, sometime severe, local toxicity. As a consequence, many patients do no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::4e12629f7f0b27411e828cdc34f22019
http://hdl.handle.net/10447/73087
http://hdl.handle.net/10447/73087
Autor:
Chiapparrone, G, Scalici Gesolfo,C, Solazzo, S, D’amato,F, Giaimo, RM, Mastrocinque, G, Scurria,S, SERRETTA, Vincenzo
Introduction: BCG maintenance for at least one year is the best regimen for prevention of recurrence and progression in high risk non muscle invasive bladder cancer (NMIBC), undergoing conservative approach. Noteworthy, a relevant number of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::f3879a6dde133d7e27dc17f388bf935e
http://hdl.handle.net/10447/73088
http://hdl.handle.net/10447/73088
Intravesical chemotherapy and immunotherapy with BCG represent the standard therapy to prevent recurrence after transurethral resection (TUR) of non-muscle invasive bladder cancer (NMI-BC). Maintenance for at least one year is considered the best reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::066bd8a0793455d230d9ec8a000d11b3
http://hdl.handle.net/10447/82303
http://hdl.handle.net/10447/82303
Autor:
SERRETTA, Vincenzo, SCURRIA, Salvatore, DISPENSA, Nino, CARUSO, Stefano, BRONTE, Giuseppe, CICERO, Giuseppe, RUSSO, Antonio, Caruana, G, Chiapparrone, G, Provenzano, S, PROVENZANO, Sandro
To reduce the number of negative prostate biopsies in patients with elevated PSA serum levels represents a major challenge in urological oncology. Angiogenetic factors might be involved in initial stages of prostate cancer and might represent useful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::026d9de9aa03e97395b9b04ead79df82
http://hdl.handle.net/10447/86608
http://hdl.handle.net/10447/86608
Autor:
Vedovo, F., Bertolotto, M., Pavan, N., Chiapparrone, G., Bucci, S., Liguori, G., Silvestri, T., Trombetta, C.
Publikováno v:
In European Urology Supplements March 2018 17(2):e1743-e1743